Nasal Polyposis: Clinical Trials

17 trials for Nasal Polyposis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 unknown, 1 not yet recruiting, 1 terminated. 6 Phase 3, 5 Phase 2, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Terminated 1, Unknown 1
Phase 25Completed 5
Not applicable3Completed 1, Not yet recruiting 1, Unknown 1

Follow Nasal Polyposis: new trials by email Literature Review of Nasal Polyposis trials Research Report on Nasal Polyposis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps
Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray, Functional Endoscopic Sinus Surgery - Chronic Sinusitis, Nasal Polyposis
Not applicableNot yet recruitingServices Institute of Medical Sciences, Pakistan1742026-10-152026-10-06
Long-term Effect of Dupilumab in N-ERD
Observational follow-up of standard Dupilumab treatment - NSAID-Induced Asthma, NSAIDs Hypersensitivity
CompletedMedical University of Vienna152025-09-012026-10-07
Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score)
Questionaries - Nasal Polyposis
CompletedCentre Hospitalier Intercommunal Creteil5692022-01-272025-02-03
Nasality Evolution in a Nasal Polyposis Context : Multiparametric Evaluation : Articulatory (Imaging), Aerodynamics, Acoustics and Perception
Nasal Polyposis
UnknownAssistance Publique - Hôpitaux de Paris302021-12-012021-11-23
Smell Exploration in Patients With Nasal Polyposis : Study by Functional Magnetic Resonance Imaging
fMRI - Nasal Polyposis
Not applicableUnknownCentral Hospital, Nancy, France602019-12-232020-11-19
Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)
Benralizumab 30 mg, Matched placebo - Nasal Polyposis, Eosinophilic Chronic Rhinosinusitis
Phase 3TerminatedAstraZeneca2952019-11-252026-02-19
Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video
Fluticasone Propionate - Nasal Polyposis
Phase 3CompletedOptinose US Inc.112018-06-072020-08-03
Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis
Benralizumab 30 mg SC + Mometasone Furoate, Matching placebo SC + Mometasone Furoate - Nasal Polyposis
Phase 3CompletedAstraZeneca4132018-01-152021-10-12
Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)
S8 Sinus Implant - Chronic Sinusitis, Nasal Polyposis
Phase 3CompletedIntersect ENT502017-11-132019-11-27
Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis
Emthexate, Prednol, Mometasone Furoate - Nasal Polyposis
Phase 2CompletedDokuz Eylul University412017-09-022020-08-31
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis
botox injection Multiguide - Chronic Disease, Nasal Polyposis
Phase 2CompletedNorwegian University of Science and Technology112016-10-012021-11-05
Study to Evaluate Multiple Doses in Patients With Nasal Polyposis
AK001 low dose, AK001 high dose, Placebo - Nasal Polyposis
Phase 2CompletedAllakos Inc.402016-04-012021-01-25
The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery
MEDIHONEY®, Budesonide, Normal saline sinus rinse - Chronic Sinusitis, Nasal Polyposis
Not applicableCompletedUniversity of Vermont Medical Center402015-11-012019-10-16
S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps
S8 Sinus Implant, Mometasone furoate nasal spray, Sham - Chronic Sinusitis, Nasal Polyposis
Phase 3CompletedIntersect ENT3002014-12-012018-08-15
The Effect of RF Turbinoplasty in Polypoid Change of Middle Turbinates
middle turbinate Radio Frequency (RF) turbinoplasty, middle turbinate resection, middle turbinate medialization - Nasal Polyposis, Sinusitis
Phase 3UnknownTehran University of Medical Sciences902011-05-012013-07-24
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
Omalizumab, Placebo - Nasal Polyposis, Asthma
Phase 2CompletedUniversity Hospital, Ghent232006-12-012011-07-13
Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis
Administration of oral methylprednisolone - Nasal Polyposis
Phase 2CompletedUniversity Hospital, Ghent482002-11-012007-12-28

Narrower conditions

Nasal Polyps (17)  ·  Asthma (2)  ·  Asthma, Aspirin-Induced (1)  ·  Bites and Stings (1)  ·  Chronic Disease (1)  ·  Nose Diseases (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Polyps (1)  ·  Respiratory Tract Diseases (1)  ·  Rhinitis (1)  ·  Sinusitis (1)

Broader conditions

Pathological Conditions, Anatomical (17)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Nose Diseases (16)  ·  Otorhinolaryngologic Diseases (16)  ·  Polyps (16)  ·  Respiratory Tract Diseases (16)  ·  Bronchial Diseases (3)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Respiratory Hypersensitivity (3)  ·  Chemically-Induced Disorders (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)

Interventions

Mometasone Furoate (3)  ·  benralizumab (2)  ·  Adrenal Cortex Hormones (1)  ·  Botulinum Toxins, Type A (1)  ·  Budesonide (1)  ·  Fluticasone (1)  ·  Magnetic Resonance Imaging (1)  ·  Methotrexate (1)  ·  Methylprednisolone (1)  ·  Omalizumab (1)  ·  Prednisone (1)  ·  salicylhydroxamic acid (1)

Sponsors

AstraZeneca (2)  ·  Intersect ENT (2)  ·  University Hospital, Ghent (2)  ·  Allakos Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Central Hospital, Nancy, France (1)  ·  Centre Hospitalier Intercommunal Creteil (1)  ·  Dokuz Eylul University (1)  ·  Medical University of Vienna (1)  ·  Norwegian University of Science and Technology (1)  ·  Optinose US Inc. (1)  ·  Services Institute of Medical Sciences, Pakistan (1)  ·  Tehran University of Medical Sciences (1)  ·  University of Vermont Medical Center (1)

Countries

United States (7)  ·  Belgium (5)  ·  France (4)  ·  Austria (2)  ·  Germany (2)  ·  Hungary (2)  ·  Poland (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Australia (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Denmark (1)

Top investigators

Babak Saedi, professor (1)  ·  Claus Bachert (1)  ·  Claus Bachert, MD, PhD (1)  ·  Claus Bachert, Prof. dr. h.c. (1)  ·  Daniyal Babar (1)  ·  Gary P Landrigan, MD (1)  ·  Jennifer Carothers (1)  ·  John Messina (1)  ·  Jose P. Stolovitzky, MD (1)  ·  Lars Jacob Stovner, md prof (1)  ·  Luo Zhang, Prof. Dr. (1)  ·  Paul Van Cauwenberge, PhD, MD (1)  ·  Peter Manes, MD (1)

Results publications

PMID 33710614, PMID 34110505, PMID 34599979, PMID 34633904, PMID 36549708

NIH funding

2015 (1), 2017 (1), 2023 (1)